Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$1.139M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
1.72%
Q3 2024
Total Assets
Total Liabilities
Q3 2024
Book Value
Cash
Q3 2024
P/E
-2.109
Nov 29, 2024 EST
Free Cash Flow
-$457.9K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Revenue $0.00 $0.00 $0.00 $0.00 $3.455M $2.510M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 37.61%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Revenue $0.00 $0.00 $0.00 $0.00 $3.455M $2.510M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue $0.00 $0.00 $0.00 $0.00 $3.246M $782.7K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00 $208.5K $1.728M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Margin 6.03% 68.82%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Selling, General & Admin $1.672M $1.869M $2.002M $5.742M $13.40M $19.55M $8.933M $6.959M $7.974M $190.0K $80.00K $100.0K $250.0K $2.640M $120.0K $150.0K $450.0K
YoY Change -10.51% -6.64% -65.14% -57.15% -31.47% 118.87% 28.37% -12.73% 4096.76% 137.5% -20.0% -60.0% -90.53% 2100.0% -20.0% -66.67%
% of Gross Profit 6428.02% 1131.74%
Research & Development $261.6K $490.3K $821.3K $352.3K $1.543M $458.8K
YoY Change -46.65% -40.3% 133.15% -77.18% 236.41%
% of Gross Profit 220.09%
Depreciation & Amortization $620.00 $61.66K $25.78K $34.65K $541.5K $338.2K $804.8K $416.0K $177.1K $69.12K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -98.99% 139.22% -25.62% -93.6% 60.11% -57.98% 93.47% 134.86% 156.25%
% of Gross Profit 162.24% 46.58%
Operating Expenses $1.421M $1.672M $821.3K $352.3K $1.543M $458.8K $19.55M $8.933M $6.959M $7.974M $190.0K $70.00K $100.0K $250.0K $2.630M $120.0K $150.0K $450.0K
YoY Change -15.06% 103.61% 133.15% -77.18% 236.41% -97.65% 118.87% 28.37% -12.73% 4096.76% 171.43% -30.0% -60.0% -90.49% 2091.67% -20.0% -66.67%
Operating Profit -$1.421M -$1.672M -$1.869M -$2.002M -$5.742M -$13.19M -$17.82M -$190.0K -$70.00K -$100.0K -$250.0K -$2.630M -$120.0K -$150.0K -$450.0K
YoY Change -15.06% -10.51% -6.64% -65.14% -56.47% -26.0% 171.43% -30.0% -60.0% -90.49% 2091.67% -20.0% -66.67%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Interest Expense -$219.0K -$178.7K $474.8K $1.285M $1.109M $4.940M -$5.176M -$901.1K -$105.2K $0.00 $90.00K $150.0K $90.00K -$200.0K -$70.00K -$20.00K -$30.00K -$10.00K
YoY Change 22.57% -137.63% -63.07% 15.91% -77.55% -195.44% 474.43% 756.59% -100.0% -40.0% 66.67% -145.0% 185.71% 250.0% -33.33% 200.0%
% of Operating Profit
Other Income/Expense, Net $58.83K $100.0K $1.722M -$1.331M $992.5K -$8.309M -$158.2K -$248.9K -$15.00K $140.00 $0.00 $0.00 $0.00 $0.00 -$80.00K -$200.0K $0.00
YoY Change -41.17% -94.19% -229.37% -234.14% -111.94% 5151.66% -36.43% 1559.07% -10814.29% -100.0% -60.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Pretax Income -$1.362M -$4.125M -$146.5K -$3.333M -$4.749M -$21.50M -$23.16M -$10.08M -$7.079M -$7.974M -$660.0K $40.00K -$10.00K -$590.0K -$2.960M -$340.0K -$180.0K -$460.0K
YoY Change -66.99% 2715.29% -95.6% -29.82% -77.91% -7.17% 129.68% 42.44% -11.22% 1108.14% -1750.0% -500.0% -98.31% -80.07% 770.59% 88.89% -60.87%
Income Tax $0.00 $0.00 $0.00 $0.00 $526.1K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$1.362M -$4.125M -$530.9K -$3.725M -$12.37M -$23.65M -$22.97M -$9.910M -$6.771M -$7.723M -$660.0K $40.00K -$10.00K -$590.0K -$2.960M -$340.0K -$100.0K -$560.0K
YoY Change -66.99% 677.06% -85.75% -69.9% -47.69% 2.96% 131.83% 46.35% -12.32% 1070.12% -1750.0% -500.0% -98.31% -80.07% 770.59% 240.0% -82.14%
Net Earnings / Revenue -684.7% -915.18%
Basic Earnings Per Share $0.00 -$0.01 $0.00 -$0.01
Diluted Earnings Per Share $0.00 -$0.01 -$1.671K -$13.06K -$47.88K -$112.9K -$172.8K -$125.4K -$150.8K -$261.6K -$702.1K $41.24K -$3.356K -$831.0K -$6.884M -$3.778M -$1.111M -$7.000M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Cash & Short-Term Investments $11.99K $109.9K $233.9K $793.0K $151.8K $227.8K $3.580M $2.693M $34.82K $0.00 $340.0K $0.00 $0.00 $50.00K $20.00K $0.00 $0.00 $70.00K
YoY Change -89.09% -53.01% -70.51% 422.53% -33.36% -93.64% 32.93% 7633.92% -100.0% -100.0% 150.0% -100.0%
Cash & Equivalents $11.99K $109.9K $233.9K $793.0K $151.8K $227.8K $3.580M $2.693M $34.82K $0.00 $340.0K $0.00 $0.00 $50.00K $20.00K $0.00 $0.00 $70.00K
Short-Term Investments
Other Short-Term Assets $91.45K $199.6K $93.93K $2.751M $60.89K $614.2K $1.957M $166.4K $104.9K $190.4K $0.00 $0.00 $0.00 $20.00K $80.00K $0.00 $0.00
YoY Change -54.18% 112.49% -96.59% 4417.67% -90.09% -68.61% 1076.06% 58.68% -44.92% -100.0% -75.0%
Inventory $1.446M $2.137M $1.049M $89.04K $0.00 $30.00K
Prepaid Expenses
Receivables $118.0K $488.3K $667.1K $0.00 $67.86K $50.00K $150.0K $0.00 $0.00 $280.0K
Other Receivables $5.224M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $103.4K $309.5K $327.8K $3.544M $7.001M $3.467M $7.253M $2.948M $207.5K $240.4K $490.0K $10.00K $10.00K $70.00K $100.0K $10.00K $0.00 $380.0K
YoY Change -66.58% -5.59% -90.75% -49.38% 101.94% -52.2% 146.0% 1320.63% -13.66% -50.94% 4800.0% 0.0% -85.71% -30.0% 900.0% -100.0%
Property, Plant & Equipment $0.00 $25.02K $5.561M $23.50M $13.76M $8.643M $1.953M $913.6K $40.00K $0.00 $40.00K $40.00K $170.0K $0.00
YoY Change -100.0% -99.55% -76.34% 70.83% 59.2% 342.52% 113.77% 2184.1% -100.0% 0.0% -76.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets $0.00 $5.530M $91.50K $1.233M $1.633M $1.261M $275.0K $297.5K $0.00 $0.00
YoY Change -100.0% 5944.17% -92.58% -24.51% 29.52% 358.55% -7.55%
Total Long-Term Assets $0.00 $42.82K $2.222M $7.262M $7.352M $26.56M $16.80M $10.06M $2.228M $1.211M $50.00K $0.00 $30.00K $30.00K $170.0K $0.00 $0.00 $0.00
YoY Change -100.0% -98.07% -69.4% -1.22% -72.32% 58.1% 66.99% 351.45% 83.97% 2322.24% -100.0% 0.0% -82.35%
Total Assets $103.4K $352.3K $2.550M $10.81M $14.35M $30.02M $24.05M $13.01M $2.436M $1.451M $540.0K $10.00K $40.00K $100.0K $270.0K $10.00K $0.00 $380.0K
YoY Change
Accounts Payable $2.140M $1.983M $1.657M $1.412M $2.560M $3.071M $371.9K $176.2K $902.1K $677.2K $20.00K $10.00K $10.00K $0.00 $0.00 $10.00K $20.00K $230.0K
YoY Change 7.95% 19.66% 17.31% -44.82% -16.64% 725.63% 111.14% -80.47% 33.21% 3286.15% 100.0% 0.0% -100.0% -50.0% -91.3%
Accrued Expenses $457.1K $422.4K $394.4K $1.537M $1.879M $605.5K $492.0K $496.7K $896.1K $73.01K $250.0K $250.0K $180.0K $140.0K $90.00K $60.00K $30.00K $100.0K
YoY Change 8.2% 7.11% -74.33% -18.24% 210.41% 23.07% -0.95% -44.58% 1127.41% -70.8% 0.0% 38.89% 28.57% 55.56% 50.0% 100.0% -70.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $151.9K $0.00 $0.00 $0.00 $0.00 $0.00 $1.260M $670.0K $750.0K $890.0K $690.0K $300.0K $160.0K $200.0K
YoY Change -100.0% -100.0% 88.06% -10.67% -15.73% 28.99% 130.0% 87.5% -20.0%
Long-Term Debt Due $1.437M $1.396M $987.6K $3.595M $5.702M $2.530M $1.056M $2.730K $463.5K $30.00K $10.00K $0.00
YoY Change 2.95% 41.37% -72.53% -36.95% 125.37% 139.5% 38592.31% -99.41% 1445.1% 200.0%
Total Short-Term Liabilities $5.096M $4.760M $3.935M $8.598M $10.89M $6.712M $1.920M $675.6K $2.262M $2.507M $1.550M $1.200M $1.270M $1.420M $1.070M $360.0K $220.0K $560.0K
YoY Change 7.06% 20.94% -54.23% -21.01% 62.18% 249.56% 184.23% -70.13% -9.79% 61.75% 29.17% -5.51% -10.56% 32.71% 197.22% 63.64% -60.71%
Long-Term Debt $322.0K $0.00 $397.3K $292.4K $3.533M $6.155M $6.498M $3.927M $2.149M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% 35.87% -91.72% -42.6% -5.27% 65.48% 82.76%
Other Long-Term Liabilities $0.00 $3.389M $22.52K $0.00 $875.5K $0.00
YoY Change -100.0% 14949.38% -100.0%
Total Long-Term Liabilities $322.0K $0.00 $397.3K $3.682M $3.556M $6.155M $6.498M $3.927M $2.149M $875.5K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -89.21% 3.54% -42.23% -5.27% 65.48% 82.76% 145.42%
Total Liabilities $5.418M $4.760M $4.333M $12.28M $14.44M $21.72M $11.30M $4.680M $4.332M $3.132M $1.550M $1.200M $1.270M $1.420M $1.070M $360.0K $220.0K $560.0K
YoY Change 13.82% 9.85% -64.72% -14.97% -33.52% 92.22% 141.49% 8.03% 38.32% 102.05% 29.17% -5.51% -10.56% 32.71% 197.22% 63.64% -60.71%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Basic Shares Outstanding 396.7M 357.7M 317.6M 285.2M
Diluted Shares Outstanding 343.5M 342.3M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $2.4017 Million

About GB SCIENCES INC

GB Sciences, Inc. is a biopharmaceutical research and development company, which engages in creating patented, disease-targeted formulations of cannabis, and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The company is headquartered in Las Vegas, Nevada and currently employs 2 full-time employees. The company went IPO on 2003-12-22. The company creates patented, disease-targeted formulations of cannabis and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. (GBSGB). The primary focus for the development of its lead program has been in evaluating suitable development partners that will assist it in preparing its cannabinoid-based formulas for the treatment of the motor symptoms of Parkinson's disease in human clinical trials. The company is engaged in the research and development of plant-inspired medicines, with virtual operations in North America and Europe. GBSGB’s has a portfolio of intellectual property containing both proprietary plant-inspired formulations and its artificial intelligence-enabled drug discovery platform, and critical research contracts and key supplier arrangements. Its intellectual property covers a range of 65 medical conditions.

Industry: Crude Petroleum & Natural Gas Peers: CLS Holdings USA, Inc. ADIAL PHARMACEUTICALS, INC. Emmaus Life Sciences, Inc. ARTELO BIOSCIENCES, INC. Cingulate Inc. JOHNSON & JOHNSON RANGE IMPACT, INC. Petros Pharmaceuticals, Inc.